Biovie
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -229,376,827 | -57 | -57 | -57 |
EBITDA | -3,426 | -2,726 | -6,988 | -3,839 |
EBIT | -3,484 | -2,783 | -7,045 | -3,896 |
Net Income | -3,489 | -2,788 | -7,157 | -4,152 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -5,607 | -1,253 | -8,584 | -3,579 |
Cash | 17,544 | 23,152 | 24,405 | 20,023 |
Basic Shares | 14,773 | 1,850 | 1,571 | 639 |
Annual Financials
| Values in thousands | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -229,377,000 | -229 | -266 | -237 |
EBITDA | -18,066 | -31,950 | -44,851 | -26,980 |
EBIT | -18,307 | -32,179 | -45,080 | -27,209 |
Net Income | -17,911 | -32,121 | -50,256 | -26,084 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | 14,130 | |||
Free Cash Flow | -19,025 | -27,945 | -40,252 | -18,990 |
Cash | 17,544 | 23,843 | 19,460 | 18,641 |
Basic Shares | 1,477 | 451 | 324 | 246 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$11.05 |
2025-03-31 | -$1.50 |
2024-12-31 | -$4.60 |
2024-09-30 | -$0.69 |
